KRASG12D选择性VHL-PROTAC与节省的KRASWT和其他KRAS突变体
Eunhye Jeon1, Chan Kim1, Minjoo Ko1
1Department of Medical Science, Graduate School of Medical Science, Brain Korea 21 FOUR Project, Yonsei University College of Medicine, Seoul, Republic of Korea; Department of Biomedical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.
European journal of medicinal chemistry
|July 12, 2025
概括
研究人员开发了一种名为CH091138的新型蛋白质溶解向金马 (PROTAC),可以选择性降解KRAS G12D突变蛋白,这是许多癌症的常见驱动因素,提供了一种有前途的新抗癌策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- KRAS G12D突变在各种癌症中普遍存在,导致瘤生长.
- 准KRAS G12D是癌症治疗中的一个重大挑战.
- 现有的疗法往往缺乏选择性,导致非目标效应.
研究的目的:
- 为了识别和表征一种新的KRAS G12D选择性蛋白解-向金梅拉 (PROTAC).
- 调查发现的PROTAC的作用机制和选择性.
- 在临床前模型中评估PROTAC的抗癌疗效.
主要方法:
- 结构-活动关系 (SAR) 研究用于PROTAC优化.
- 生物化学测试以评估蛋白质降解.
- 全球蛋白质组分析以确定目标参与.
- 核磁共振 (NMR) 和对接研究用于结合部位的识别.
- 实验室细胞增殖试验和体内异种移植小鼠模型.
主要成果:
- CH091138 (6) 被确定为一种选择性降解KRAS G12D.的PROTAC.
- 证实了外源和内源KRAS G12D的降解,对KRAS WT或其他突变没有影响.
- 蛋白质组分析显示,在AsPC-1细胞中,KRAS下调显著.
- 机制涉及VHL介导的无素-蛋白酶体系统.
- 核磁共振和对接研究阐明了赋予选择性的结合相互作用.
- CH091138抑制了KRAS G12D突变癌细胞和器官的增殖.
- 在异种移植小鼠模型中观察到显著的瘤生长减少.
结论:
- CH091138是KRAS G12D降解的一种强效和选择性的PROTAC.
- 这项研究提供了对PROTAC介导的KRAS G12D选择性的机制性见解.
- 通过PROTAC介导的KRAS G12D降解是一种有前途的抗癌治疗策略.
相关概念视频
The Ras Gene
6.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.4K
In-vitro Mutagenesis
14.2K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.2K


